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Abstract: Type 2 diabetes is an increasing health concern worldwide. Both genetic and environmental
risk factors as improper dietary habits or physical inactivity are known to be crucial in the pathogen-
esis of type 2 diabetes. Polyphenols are a group of plant-derived compounds with anti-inflammatory
and antioxidant properties that are associated with a low prevalence of metabolic conditions charac-
terized by insulin resistance, including obesity, diabetes, and hypertension. Moreover, there is now
full awareness that foods that are rich in phytochemicals and polyphenols could play an important
role in preserving human cardiovascular health and substantial clinical evidence indicates that regu-
lar dietary consumption of such foods affects favorably carbohydrate metabolism. This review briefly
summarizes the evidence relating dietary patterns rich in polyphenols with glucose metabolism and
highlights the potential benefits of these compounds in the prevention of type 2 diabetes.
Keywords: polyphenols; diet; dietary patterns; diabetes
1. Introduction
The chemical structure of phenols is characterized by an aromatic ring with at least
one hydroxyl group and can vary [1] from simple molecules to complex polymers with high
molecular weight. Although there is some disagreement concerning their categorization, a
classification that has been commonly used in the medical literature subdivides phenols in
two main groups: Flavonoids and non-flavonoid polyphenols [2,3]. The flavonoid group
comprises flavanones, flavones, dihydroflavonols, flavonols, flavan-3-ols, isoflavones, an-
thocyanidins, proanthocyanidins, and chalcones, all compounds with a C6-C3-C6 structure.
Non-flavonoid polyphenols are classified on the basis of their carbon skeleton into different
subgroups: Simple phenols, benzoic acids, hydrolysable tannins, acetophenones, pheny-
lacetic acids, cinnamic acids, lignans, coumarins, benzophenones, xanthones, stilbenes, and
secoiridoids [4].
Hundreds of different polyphenols are found in plant-based foods (Appendix A
Table A1) including fresh vegetables (e.g., broccoli, onion, cabbage, garlic, asparagus,
carrots), fruits (grapes, pears, apples, cherries, and various berries), legumes (soybean), and
cereals (whole grains). Other relevant dietary sources of polyphenols are identified in plant-
derived beverages such as chocolate, coffee, tea, red wine, or extra-virgin olive oil [5,6].
There is now full awareness that foods that are rich in phytochemicals and polyphenols
could play an important role in preserving human cardiovascular (CV) health [7], and
substantial clinical evidence indicates that regular dietary consumption of such foods
favorably affects carbohydrate metabolism [8]. This review briefly summarizes the evidence
relating to dietary patterns rich in polyphenols with glucose metabolism and highlights
the potential benefits of these compounds in the prevention of type 2 diabetes.
2. Dietary Pholyphenols and Diabetes Risk
High amounts of polyphenols are present in some diets such as the Mediterranean
and the plant-based diet. The Mediterranean diet essentially refers to a dietary pattern rich
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in whole grains, fruits and vegetables, legumes, nuts, fish, olive oil, and with moderate
wine consumption. It has been estimated that adherence to a Spanish Mediterranean
diet led to a daily intake of polyphenols between 2590 and 3016 mg/die [9]. Plant-based
diets involve eating plenty of vegetables, fruits, and cereals and a low amount of animal
products; among plant-based diets, Pesco-Vegetarian, Semi-Vegetarian, and Lacto-ovo-
Vegetarian diets contain the greatest amounts of polyphenols [10]. It is known that both
the Mediterranean and plant-based diets are deemed “healthy diets” because, due to their
content in polyphenols, they have been shown to improve carbohydrate metabolism and
glucose tolerance [11]. Therefore, the potential benefit of these diets for prevention of
type 2 diabetes has been tested in intervention studies. A prospective study that included
6798 participants from the Rotterdam Study demonstrated that high adherence to a plant-
based versus animal-based diet was associated with a lower risk of insulin resistance,
prediabetes, and diabetes, even after adjusting for confounders such as sociodemographic
and lifestyle factors (food supplements, medications use, physical exercise) [12]. Similar
findings were obtained from the pooled analysis of three big databases (Nurses’ Health
Study, Nurses’ Health Study 2 and Health Professionals Follow-Up Study) [13] in which a
healthful plant-based diet rich in whole grains, fruits, vegetables, nuts, legumes, vegetable
oils, and tea/coffee was associated with substantially lower risk of developing type 2
diabetes during the follow-up. Furthermore, as demonstrated in a meta-analysis that
included data from 307,099 patients [14], plant-based diets that are enriched with healthful
plant-based foods are beneficial for the primary prevention of type 2 diabetes. On the other
hand, at least five large prospective studies reported a substantially lower risk to develop
type 2 diabetes in healthy or at-risk subjects who ate a Mediterranean diet [15]. To date, the
relative contribution of single components of the Mediterranean or the plant-based diets to
type 2 diabetes prevention is not clearly understood.
In this context, the role of specific dietary components including a group of polyphe-
nols has been extensively studied in the last decade. A randomized controlled trial reported
that a diet naturally rich in polyphenols improves glucose metabolism in individuals at high
risk of diabetes [16]. A meta-analysis of six prospective cohorts that involved 284,806 par-
ticipants suggested that an increase in the total dietary flavonoids intake by approximately
500 mg/day is associated with a significant decrease of the risk to develop type 2 dia-
betes [17] and, consistently, another meta-analysis of 18 prospective studies [18] showed
that diets rich in polyphenols, particularly flavonoids, play a role in the prevention of
type 2 diabetes. A large epidemiological study showed that anthocyanins-rich diets with
substantial consumption of specific whole fruits, including blueberries, grapes, and apples,
was significantly associated with a reduced risk of diabetes [19]. In a 3-month randomized,
double-blind, placebo-controlled trial of subjects with prediabetes or new onset diabetes,
purified anthocyanins moderately reduced glycated hemoglobin [20]. Another recent
study has indicated the potential benefit of anthocyanin-rich mixed berry preparations on
post-prandial glucose and insulin response [21] thereby suggesting an improved insulin
sensitivity. Further evidence comes from a recent metanalysis of 37 randomized controlled
trials that demonstrates that consumption of anthocyanins for more than 8 weeks in doses
of more than 300 mg/day significantly decreases fasting and post-prandial glucose, gly-
cated hemoglobin, and HOMA-index in overweight/obese individuals [22]. In addition,
in a Korean study involving 4186 individuals, the consumption of flavonols and flavones
was directly associated with insulin sensitivity among male subjects [23]. According to all
these studies, it could be stated that current evidence indicates the benefits of polyphenols-
enriched diets, particularly with flavonoids, on insulin sensitivity that could translate to a
significantly reduced risk to develop type 2 diabetes. It is appropriate, however, to mention
that other studies have not confirmed this evidence [24] and a prospective, cross-sectional
analysis of 38,018 women reported did not observe any relationship between flavonols or
flavones dietary intake and the risk of type 2 diabetes, and the intake of anthocyanidins
was not linked to the risk of diabetes [25]. Inconsistencies among the results of these
studies might be explained by substantial differences in the populations included the use
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of different types of polyphenols sources, adherence to dietary prescriptions with possible
assessment of dietary intake, and the duration of exposure.
3. Specific Dietary Sources of Polyphenols and Diabetes Risk
3.1. Grains and Soy
Regular consumption of whole-grain products has been associated with a significant
reduction in the risk of type 2 diabetes and lower CV mortality in many prospective
studies [26–28]. Inverse associations between whole-grain intake, fasting insulin, and
insulin sensitivity have been reported [29], although differences may occur due to grain
variety. For instance, whole-wheat breads are associated with lower glycemic responses
than white bread [30], and this has been attributed, at least in part, to the polyphenols
content in the bran fraction of whole wheat [31]. It was demonstrated that ferulic acid
contained in whole grains decreases cellular glucose uptake into epithelial cells in the small
intestine and therefore might account for the attenuation of postprandial hyperglycemia
by inhibition of glucose absorption [32]. Although dietary intake of soy protein and soy
isoflavones was found to be inversely related to new onset type 2 diabetes in two meta-
analyses of prospective studies [33,34], the evidence currently available on the possible
benefits of soy on glucose metabolism is still preliminary and needs further investigation.
3.2. Fruits and Vegetables
Apples are rich in bioactive polyphenols and were found to decrease postprandial
blood glucose in two small randomized controlled trials [35,36] conducted in healthy
subjects. However, a recent study of subjects who consumed apples on a regular basis did
not show any improvements of fasting blood glucose or serum insulin when compared to
controls [37].
It is well known that berries are rich in polyphenols and contain a wide variety of
phenolic molecules, ranging from phenolic acids (hydroxybenzoic and hydroxycinnamic
acids), flavonoids (anthocyanins, flavonols, and flavan-3-ols) to polymerized compounds
(proanthocyanins and ellagitannins) [38]. In a study conducted in prediabetic subjects with
an oral glucose test, raspberry reduced the post-glucose load peak serum glucose and in-
sulin levels and the area under the curve of glucose and insulin response [39]. In an elegant
double-blind randomized controlled trial, consumption of 333 mg/day of polyphenols
from strawberries and cranberries for 6 weeks improved insulin sensitivity and decreased
compensatory insulin hypersecretion in patients with overweight [40]. Conversely, findings
of other studies indicate that daily consumption of cranberry beverages for 8 weeks does
not improve insulin sensitivity [41] and consumption of 140 g/day of blueberries with a
carbohydrate breakfast meal does not affect glucose metabolism, nor the gastrointestinal
hormones Glucagon Like Peptide 1 (GLP-1), Gastro Inhibitory Peptide, and peptide YY.
Also, pomegranate has an elevated content of bioactive polyphenols, and possible
glucose-lowering effects of this fruit have been reported in animal studies [42], but in-
tervention studies in humans have generated controversial results. In a randomized,
cross-over, controlled study on healthy volunteers, beverages containing pomegranate
polyphenols (mainly tannins) were found to reduce the postprandial glycemic response to
a bread meal [43]. However, a meta-analysis of 16 randomized controlled trials showed
that pomegranate intake did not have any favorable effect on glucose metabolism and
insulin sensitivity [44].
Among additional promising antidiabetic compounds, citrus flavonoids were reported
to modulate the intracellular pathways related to cell glucose uptake and insulin sensitivity
and therefore they might have relevance in the prevention of diabetes, although this role
needs to be verified in appropriately designed human studies [45].
Because of its abundant content of polyphenols, kiwifruit was sought to have beneficial
metabolic effects, mostly relevant for carbohydrate metabolism. However, a meta-analysis
of five randomized controlled trials has reported no favorable metabolic effect of kiwifruit
in patients with cardiovascular risk factors [46].
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Onion bulbs are one of the greater sources of dietary flavonoids and contribute
significantly to the overall intake of flavonoids in common diets [47]. Preclinical studies
suggested that onion bulbs and its active components may be considered as prophylactic
or therapeutic agents against diabetes through a variety of mechanisms including an
antioxidant, α-glucosidase, and α-amylase inhibitory effect, up-regulation of adiponectin
receptors, reduction of insulin resistance and glucose intestinal absorption, elevation of
hepatic and muscular glycogen content, increase of insulin secretion, and phosphorylation
of AMP-activated protein kinase [48]. The metabolic effects of onion consumption were
tested in a randomized controlled trial conducted in overweight/obese women with
polycystic ovary syndrome reporting no significant difference in fasting blood sugar after
8 weeks [49]. In another randomized, placebo-controlled, 8-week trial, dietary raw yellow
onion at the doses of 100 to 160 g/day improved doxorubicin-related insulin resistance
and hyperglycemia in women with breast cancer [50].
Broccoli and broccoli sprouts are important sources of bioactive compounds including
isothiocyanates, glycosylates, flavonoids, and phenols, all compounds that may improve
insulin resistance. In a small randomized clinical trial, the consumption of 10 g/day of
broccoli sprouts for 4 weeks resulted in a significant decrease in fasting serum insulin
concentration and HOMA-index [51]. In another open trial, a combined meal of cooked
broccoli and mashed potato had significantly lower serum glucose and insulin responses
in comparison to potato eaten alone, suggesting that broccoli favorably affect glucose
homeostasis [52].
In summary, polyphenols are contained in many fruits and vegetables whose effects
could contribute significantly to an improvement of glucose metabolism and insulin sensi-
tivity, possibly leading to the prevention of type 2 diabetes. However, the evidence obtained
in intervention studies is still controversial for many types of fruits and vegetables and
will need more extensive investigation before these dietary recommendations could be
considered as mandatory in subjects at risk of developing type 2 diabetes.
3.3. Olive Oil
Extra-virgin olive oil is one of the components that most differentiates the Mediter-
ranean diet from other dietary patterns. Phenolic compounds such as oleuropein and
hydroxytyrosol, flavonoids, especially flavones, and lignans are abundant in extra-virgin
olive oil [53]. The phenolic composition of olive oil ranges from 50 to 800 mg/L depending
upon several factors including, among others, variety, cultivation techniques, degree of
ripeness, and climate [54].
The effects of olive oil consumption on prevention of type 2 diabetes have been tested
in many randomized clinical trials. The PREDIMED trial examined the effects on glucose
metabolism of a Mediterranean diet with extra supplements of extra-virgin olive oil [55]
and showed that this diet lowered the risk of type 2 diabetes by 40% in patients with high
cardiovascular risk in comparison to a control group. Other analyses of the PREDIMED
trial showed a significant reduction of new-onset type 2 diabetes in elderly individuals
with the highest dietary intake of phenols and an inverse correlation between the degree of
obesity and phenol consumption [56].
Recently, the PREDIABOLE study has tested the effect of increased intake of oleanolic
acid on new-onset diabetes in prediabetic subjects [57]. In another randomized cross-over
study of 30 patients with impaired fasting glucose, a meal containing 10 g of extra-virgin
olive oil decreased blood glucose levels probably by inhibition of Dipeptidyl-peptidase-
4 activity and increase of insulin and GLP-1 secretion [58]. The potential benefits of
olive oil for the prevention of type 2 diabetes have been confirmed in a meta-analysis of
29 prospective studies in which the highest olive oil dietary intake category showed a 16%
reduction in the risk of type 2 diabetes [59]. Thus, current evidence suggests that diets
enriched with olive oil might prevent new-onset diabetes, an effect that, at least in part,
could be attributed to the polyphenol content of oil.
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3.4. Red Wine
A moderate and regular wine consumption is another typical component of the
Mediterranean diet. Polyphenols are highly concentrated in red wine and come from the
skin and seeds of grapes extracted during fermentation. The amount of polyphenols in
a glass of red wine is approximately 200 mg compared with the 30 mg contained in a
glass of white wine. Results of a small randomized controlled trial involving men at high
cardiovascular risk support the hypothesis of a beneficial effect of the non-alcoholic fraction
of red wine (mainly polyphenols) on insulin-resistanc; moreover, polyphenols of red wine
were reported to be beneficial on and plasma lipids concentrations [60].
Resveratrol is a stilbenoid present in a variety of plants, such as Polygonum cuspida-
tum, grapes, and peanuts, and is considered one of main polyphenolic compounds of red
wines. Experimental animal and human studies have shown that resveratrol has many
beneficial metabolic effects due to its ability to improve insulin sensitivity and beta-cell
function [61]. A meta-analysis of 30 studies that evaluated the effect of resveratrol on
glucose, insulin, and glycated hemoglobin levels and insulin resistance (HOMA-index)
reported a significant reduction of fasting glucose and insulin levels but no significant
changes in glycated hemoglobin and HOMA-index.
In summary, there is currently limited evidence of the effect of red wine polyphenols
on glucose metabolism and insulin sensitivity. More studies would be needed to better
understand the antidiabetic properties of resveratrol, as well as to define the therapeutic
potential of other stilbenes in the prevention of type 2 diabetes.
3.5. Tea, Coffee, and Chocolate
Encouraging data regarding the capacity of polyphenols to prevent type 2 diabetes
were obtained in studies that investigated the effects of phenolic acids contained in tea and
coffee in China and Japan [62,63]. In a randomized, controlled, cross-over study of obese
subjects, a daily dose of flavonoid-rich black tea decreased postprandial glucose and insulin
concentrations [64]. Green tea was superior to metformin in improving glycemic control in a
randomized controlled trial conducted in 120 non-diabetic overweight women [65]. A meta-
analysis of 17 randomized studies showed that green tea had favorable effects on glucose
metabolism, decreasing fasting glucose and glycated hemoglobin concentrations [66].
Conversely, another meta-analysis of seven trials reported that consumption of green tea
did not affect fasting plasma glucose and insulin levels, post-load plasma glucose, glycated
hemoglobin, and HOMA-index in subjects at risk of new-onset type 2 diabetes [67].
A recent meta-analysis of 28 prospective studies on 1,109,272 non-diabetic subjects
showed a 33% lower incidence of type 2 diabetes in habitual coffee drinkers (one to six
cups of coffee/day, with and without caffeine) than in non-consumers [68]. However, in
another study conducted in healthy subjects, coffee beverages with different contents of
chlorogenic acids did not show any significant effect on glucose or insulin responses [69].
Cocoa flavanols are present in good amounts in dark chocolate, with a content of
catechin and epicatechin (estimated to be approximately 20 times higher than in tea [70])
that was reported to have some beneficial effects on glucose metabolism. Furthermore,
a meta-analysis of 42 randomized controlled trials with acute or chronic consumption
of chocolate or cocoa reported an improvement in insulin sensitivity associated with a
decrease in serum insulin [71]. Cocoa-related polyphenol intake may also result beneficial
in reducing appetite and body weight although this effect needs further investigation [72].
4. Conclusions
In conclusion, although many epidemiological studies suggest that diets based on
foods rich in polyphenols are associated with a significant reduction in the risk of devel-
oping type 2 diabetes, findings of studies on specific compounds are still controversial
(Appendix A Table A2). This might be due to broad differences in the populations included
in studies, the types of food, the assessment of dietary intake, and the duration of exposure.
Furthermore, foods are a source of several types of polyphenols so the potential benefits
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on glucose metabolism are more likely to be mediated by the mixture and integration
of them than the activity of a single compound. Thus, to date, it is not possible to draw
definitive conclusions on the effects of specific polyphenols on glucose metabolism and on
their possible role in prevention of type 2 diabetes. More evidence obtained in accurately
designed dietary studies will be needed before polyphenol-rich foods could be includes as
a mainstay of the dietary prescription in subjects at risk of type 2 diabetes.
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Appendix A
Table A1. Polyphenol content of foods and their effects on glucose metabolism. * data adapted from http://phenol-explorer.
eu/cite_us database (accessed on 29 March 2021) ◦ data From J Pèrez-Jimenez et al. European Journal of Nutrition (2010) 64
S112 S120 [73].
Dietary Source Polyphenols Content (Class) * Main Contentfor Serving ◦







14 mg Reduction of fasting insulin and insulin resistance.








149 mg Reduction of Postprandial Glucose















390 mg Improved insulin sensitivity, decreased insulinhypersecretion.
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Table A2. Preclinical studies mentioned in the manuscript, study design, main objectives, and findings.
Design Main Objectives Main Findings
Shamloo M et al.
[30] Experimental on cellular cultures.
Effects of Phenolic acids extracted from whole
grains on glucose uptake in human Caco-2E
cells
Glucose uptake inhibition was
positively associated with the
phenolic acids content.
Castro-Acosta
ML et al. [35]
Double blind, crossover trial in 25
healthy subjects and in vitro
study of possible mechanism.
Evaluate the effects of Apple and blackcurrant
polyphenols rich drinks versus placebo on
post-prandial glucose and incretin response to
meal in humans.
Apple Polyphenols reduce
postprandial insulin, C-Peptide and
insulin area under the curve at 30 min.
Prpa E J et al. [36]
Double blind, crossover acute trial
in 34 healthy subjects an in vitro
study of possible mechanism.
Evaluate the effect of Apple Extract (with
different content of polyphenols and phlorizin)
vs. placebo on post-prandial glucose.
Test the capacity of Apple Extract to inhibit
cellular glucose transport
Polyphenol enriched apple extract
reduced plasma glucose and insulin
area under the curve at 30 min.
In vitro model apple extract inhibits
cellular glucose uptake in a dose
dependent manner.
Xiao D. et al. [39]
Controlled three arm
single-blinded, crossover
randomized clinical trial in 32
adults with obesity and
insulin resistance.
Evaluate the effect of red raspberry intake
versus placebo on meal induced
metabolic responses.
Compared to placebo Red raspberry
reduced insulin area under the curve,
peak glucose, peak insulin ad 2 h
glucose area under the curve.
Paquette M, et al.
[40]
Parallel double blind controlled
and randomized trial in 41
overweight subjects
Evaluate the effect of strawberry and
cranberry polyphenols consumption on
insulin sensitivity, glucose tolerance and
insulin secretion using the euglycemic
iperinsulinemic clamp technique.
6 weeks consumption of strawberry
and cranberry extract was associated
to significant improvement in insulin
sensitivity and insulin secretion.
Hsia DS, et al.
[41]
Parallel double blind controlled
and randomized trial in 35
overweight subjects
Evaluate the effect of cranberry consumption
on insulin sensitivity, glucose tolerance and
insulin secretion using the euglycemic
iperinsulinemic clamp technique.
8 weeks consumption of cranberry
extract has no effects on insulin
sensitivity and insulin secretion.
Kerimi A. et al.
[42]
double blind randomized,
crossover, controlled trial in 16
healthy subjects
Evaluate versus placebo the acute effect of
pomegranate juice and polyphenol rich extract
from pomegranate on the bread derived
postprandial blood glucose concentration.






randomized controlled trial in 53
overweight woman with
polycystic ovarian syndrome
Evaluate the effect of 8-week consumption of
raw red onion consumption on
metabolic features.
No effects of fasting glucose, modest
cholesterol lowering activity.
Jafarpour-
Sadegh F et al.
[50]
parallel, triple blind controlled
and randomized trial in 56
woman with breast cancer treated
with doxorubicin.
Evaluate the effect of 8-week consumption of
fresh yellow onion consumption on
glucose metabolism.
Higher consumption of fresh yellow
onion was associated with reduced
fasting glucose and decreased
insulin resistance.
Carnevale R et al.
[58]
randomized, crossover, controlled
trial in 30 subjects
with prediabetes
Effects of 10 g extravirgin olive oil on
post-prandial glucose and incretins
Extravirgin olive oil improved
postprandial glucose an was
associated with reduced activity of
dipeptidyl-peptidase 4 and increased
postprandial concentration of




trial in 67 subjects with high
cardiovascular risk
Effects of 4 week consumption of
dealcoholized red wine on
glucose metabolism.
Consumption of dealcoholized red
wine (with main content of
polyphenols) reduced insulin




crossover, controlled trial in 120
non diabetic overweight woman
Evaluate effect of 12 week consumption of
green tea versus 1 g metformin on
glycemic control
Green tea consumption had similar
effects to metformin on
glycemic control.
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